Merck successful symposium on Niaspanor

Published: 2006-04-20 07:00:00

Updated: 2006-04-20 07:00:00

During the 5th Asia Pacific Society of Arteriosclerosis and Vascular Diseases (APSAVD) in Jeju island, Merck Korea took a symposium titled "Therapeutic Innovation in Atherogenic Dyslipidemia" at Tamla hall of Jeju International Convention Center on April 13.

Prof. John Chapman of National Health and Medical Institute in Paris, France presented his paper on the subject of "Ideal management of...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.